Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-01-31
2006-01-31
Guzo, David (Department: 1636)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S186100, C424S192100, C424S204100, C435S455000, C435S456000, C435S320100, C435S325000, C435S366000, C435S371000, C536S023100, C536S023720, C514S002600
Reexamination Certificate
active
06991795
ABSTRACT:
Human Papillomavirus virus like particles (VLPs) have been constructed so that they contain a modified L2 protein. The L2 protein has been minimized and is fused to a second protein or peptide. The fused protein is incorporated into the VLP and the VLP can deliver the protein to a cell. The modified VLPs can be used to increase the breadth of immune response in vaccine preparations or to deliver other proteins of interest.
REFERENCES:
patent: 5437951 (1995-08-01), Lowy et al.
patent: 5618536 (1997-04-01), Lowy et al.
patent: 5855891 (1999-01-01), Lowy et al.
patent: 6066324 (2000-05-01), Gissmann et al.
patent: 6352696 (2002-03-01), Hallek et al.
patent: WO 96/11272 (1996-04-01), None
Philip K. Nicholls et al, The Immunology of animal papillomaviruses, Veterinary Immunology and Immunopathology 73, 2000, 101-127.
Cohen, Bumps on the Vaccine Road, Science vol. 265, Sep. 1994.
Heather L. Greenstone et al. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model, vol. 95, pp. 1800-1805, Feb. 1998.
Greenstone, H. et al. “Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model”, Proc. Natl. Acad. Sci. USA, 1998, vol. 95, pp. 1800-1805.
Peng, S. et al. “Papillomavirus Virus-like Particles Can Deliver Defined CTL Epitopes to the MHC Class I Pathway”, Virology, 1998, vol. 240, pp. 147-157.
Schafer, K. et al. “Immune Response to Human Papillomavirus 16 L1E7 Chimeric Virus-Like Particles: Induction of Cytotoxic T Cells and Specific Tumor Protection”, Int. J. Cancer, 1999, vol. 81, pp. 881-888.
Cook, III James C.
Jansen Kathrin U.
Joyce Joseph G.
Ling Jessica Ching-Yee
Lowe Robert S.
Finnegan Alysia A.
Giesser Joanne M.
Guzo David
Merck & Co. , Inc.
LandOfFree
Protein delivery system using human papillomavirus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein delivery system using human papillomavirus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein delivery system using human papillomavirus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3524842